The comment period will continue through Feb. 22, 2022.Read More
Tags :U.S. Food and Drug Administration
The candidate shared his views during a nomination hearing. Read More
FDA Commissioner Janet Woodcock praises his work as ‘invaluable and instrumental.’Read More
The document includes details about what data is needed to assess user fees.Read More
Uncertainty lingers as the FDA decides the fate of the remaining marketing applications. Read More
The candidate previously led the agency in the last year’s of the Obama administration. Read More
The company’s application has been placed back into the PMTA review process.Read More
In its haste to process millions of PMTAs, the FDA took a shortcut, documents suggest. Read More
Uncertainty persists even as the FDA approves an ENDS product for marketing.Read More
The company is still seeking a judicial stay pending the outcome of its lawsuit. Read More